Cipla Strengthens Global Pharma Leadership and Access
MUMBAI, India, April 24, 2026 Cipla Limited continues to reinforce its position as a leading global pharmaceutical company, advancing...
Affordable medicine
Advertisement
PharmaResearch and Laboratoires VIVACY Forge Strategic Alliance to Distribute REJURAN Across Europe
PharmaResearch, a regenerative medicine company headquartered in South Korea, has entered a strategic distribution partnership with France-based Laboratoires VIVACY,...
Veeva Systems and Amgen Collaborate to Accelerate Innovation in Clinical Trials
Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical...
First Patient Dosed in Akeso’s Phase III Trial of Cadonilimab for Resectable Gastric Cancer
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
FDA Approves Merck Animal Health’s BRAVECTO QUANTUM – First Once-Yearly Injection Flea & Tick Protection for Dogs
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
Advertisements
FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...
IQVIA and Veeva Forge Landmark Global Partnership, Ending Legal Disputes
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
Affordable Alternative: Glenmark Announces U.S. Launch of Micafungin for Injection USP
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
Advertisement
